Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Case ReportCase Report
Open Access

Successful treatment and follow-up of a case of recurrent pseudosarcomatous myofibroblastic proliferation

Jun H. Lei, Lu Yang, Liang R. Liu and Qiang Wei
Saudi Medical Journal March 2015, 36 (3) 363-365; DOI: https://doi.org/10.15537/smj.2015.3.10149
Jun H. Lei
From the Department of Urology, West China Hospital of Sichuan University, Sichuan, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Yang
From the Department of Urology, West China Hospital of Sichuan University, Sichuan, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liang R. Liu
From the Department of Urology, West China Hospital of Sichuan University, Sichuan, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiang Wei
From the Department of Urology, West China Hospital of Sichuan University, Sichuan, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

This report describes a case of recurrent pseudosarcomatous myofibroblastic proliferation (PMP) of the bladder with a satisfactory clinical course after a 3.5-year follow-up. There is a lack of reports of successful treatment experiences on recurrent PMP of the bladder in adults. For the primary lesion, a transurethral resection of the bladder tumor (TUR-BT) was performed; for the recurrent lesion, a combination regime of TUR-BT and intravesical mitomycin C proved effective treatment. The patient did not suffer local recurrence or distal metastasis during the 3.5-year follow-up. Our experience may serve as treatment reference to urologists who encounter similar cases.

Inflammatory myofibroblastic tumor (IMT) and pseudosarcomatous myofibroblastic proliferation (PMP) of the bladder are rare entities that were first described by Roth in 1980.1 Recently, it is not clear if PMP is a “true tumor” or “benign proliferative mesenchymal lesion.” Although an overwhelming majority of reported PMP cases have been benign in nature, some researchers still consider that close surveillance is necessary owing to its histological similarity to some malignant tumors.2-5 Rosai6 found a non-random chromosomal translocation in chromosome 2p23, supporting the theory that PMPs are true neoplasms. In this study, we illustrated a locally recurrent PMP to support its clonal origin in a patient who underwent treatment with transurethral resection of the bladder tumor (TUR-BT) and chemotherapy with mitomycin C and presented a satisfactory clinical course during a 3.5-year follow-up.

Case Report

A 22-year-old male with severe anemia was transferred by ambulance to the Emergency Department at the West China Hospital, Chengdu, China. He had a 10-day history of painless gross hematuria with blood clots, which was associated with dizziness and facial pallor of onset a week prior to the initial visit. He initially visited a local hospital, but the prescribed drug therapy did not relieve his symptoms.

After admission, laboratory test results yielded a hemoglobin level of 42 g/L. Hemostasis, transfusion, and fluids were administered to achieve rehydration and increase hemoglobin levels as quickly as possible. An emergent CT scan was performed and reviewed. A 3.5 × 2.0-cm, slightly enhanced mass was observed, occupying parts of the left and superior walls of the bladder (Figure 1). Because of the diagnosis of bladder-occupying lesion with the suspicion of cancer, cystoscopy, and TUR-BT were performed. Cystoscopy demonstrated a necrotic tumor tissue and significant bleeding. During TUR-BT, we found that the tumor did not invade beyond the serosa of the bladder and that the trigone was not involved. The tumor tissue was transported to the Department of Pathology at the West China Hospital of Sichuan University for pathological diagnosis. The evaluation of the paraffin-embedded tissue indicated PMP, which was obtained one week after the patient was discharged from the hospital. Under microscopy, the field was filled with spindle myofibroblasts characterized by abundant eosinophilic cytoplasm and large nuclei (Figure 2). On immunohistochemical (IHC) evaluation, the cells were strongly positive for anaplastic lymphoma kinase-1 and vimentin, focally positive for epithelial membrane antigen, muscle-specific actin, and negative for smooth muscle actin, H-caldesmon, desmin, myogenin, human melanoma, black-45, and S-100.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Computed tomography scan of the primary lesion with a size of 3.5× 2.0-cm, as indicated by the arrow. Perivesical invasion was not seen.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

The histopathological examination revealed spindle or round myofibroblasts with red cytoplasm and large nuclei (as indicated by the black arrow); nucleoli were visible, with a certain degree of pleomorphism and mitotic figures. Cells are fascicular and staggered, with a background of interstitial edema and some inflammatory cells infiltration. Original magnification ×200.

After 4 months, he returned to our institution, complaining of discomfort in the lower abdomen. The CT scan showed a new neoplasm of approximately 2.0 × 1.0-cm, adjacent to the location of the primary tumor that had been removed previously (Figure 3). A biopsy was performed, and the pathological and IHC result identical to the original nodule, confirming the recurrence of PMP. Considering his fear on reduced quality of life and neoplasm relapse, we performed TUR-BT followed by intravesical administration of mitomycin C (40-mg regimen). Intravesical instillations were repeated once a week for 6 weeks. Further, every 3 months during the first year postoperatively and every 6 months after that, he underwent reexamination by chest radiograph, abdominal CT scan, and ultrasound to detect any disease recurrence or metastasis. After a 3.5-year follow-up, we did not find any signs of local recurrence or distal metastasis, and his clinical course has been satisfactory.

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

Computed tomography scan of the recurrent lesion with a size of 2.0×1.0-cm, as indicated by the arrow. Perivesical invasion was not seen.

Discussion

Mesenchymal myofibroblastic spindle cell proliferation is a vast and heterogeneous category that includes PMP and other entities, varying from indolent lesions to highly aggressive tumors. Genitourinary tract involvement by PMP is an extremely rare occurrence, and the most commonly occurring location is the bladder. Since 1980 to date, several designations have been proposed to describe the entities encompassed under the category of myofibroblastic proliferations of the bladder, and yet, this issue remains debatable. The terms PMP and IMT may be more frequently used than others; that is fibromyxoid pseudotumor and plasma cell granuloma. According to the World Health Organization, IMT has been defined as a low grade malignancy tumor that typically occurs in children.7 However, the relationship between PMP and IMT, and whether PMP is a post-inflammatory process, or a true neoplasm as is IMT is still subject to controversy. Very few studies have reported cases of PMP, compared with those of IMT, with a ratio of 1:8. Harik et al8 reported a rather large case series that included 42 cases of PMP, and they reported that some lesions developed spontaneously while others were secondary to instrumentation, surgery, or drugs. Herein, we reported a case of locally recurrent PMP. We did not find any evidence of urinary infection, and the patient had no history of operation or trauma; thus, our findings further support the clonal origin of PMP. Therefore, we suppose that the 2 designations, IMT and PMP, actually refer to the same entity.

Establishing a preoperative diagnosis of PMP is challenging as there are no specific clinical manifestations. Moreover, imaging examination techniques, such as CT and MRI, and cystoscopic findings are usually difficult to distinguish from malignant tumors. Therefore, the diagnosis of PMP often depends on the postoperative pathological examinations. In this case, the combination of the patient’s painless hematuria and the appearance of the lesion under cystoscopy suggested that the lesion may comprise a malignant bladder cancer, until the pathological results were obtained. The positive results of ALK-1 for the present case were consistent with those case reported in previous studies.9,10 Thus, ALK-1 is important because of its differential diagnosis with the lesions of spindle cell neoplasms, such as rhabdomyosarcoma and myxoid leiomyosarcoma, because the latter 2 are negative for ALK-1.11

Although the clonal origin of PMP is still unclear, most of the available data highlight its benign and indolent clinical course, and conservative treatment is selected in most cases. Alquati et al2 found that 65% of the reported cases were treated with TUR-BT and 27% with partial cystectomy. In the present case, we selected TUR-BT for the management of the primary and recurrent lesions. Furthermore, the bladder was washed with mitomycin C to prevent lesion recurrence, although previous researchers believed that aggressive management was unnecessary. Considering its benign pathology, the absence of recurrence on follow-up may be related to the natural history of the disease instead of to the use of mitomycin C. The follow-up result showed a satisfactory clinical course. We did not find any reports of management experiences referring to recurrent PMP lesions; thus, our case may serve as a treatment reference for urologists who encounter similar cases. It is noteworthy that the serosa of the bladder and the trigone area were not involved by either the primary or recurrent lesions. Therefore, a closer follow-up regime may be required for cases of lesions beyond the serosa and multiple, or large lesions.

In conclusion, we present a successful treatment experience for a rare case of bladder PMP with local recurrence in a young male. As most PMPs are generally benign and do not metastasize, upon recurrence, an aggressive management may be considered with close follow-up.

Acknowledgment

We would like to express our gratitude to Prof. Jiang for preparing and reviewing the figures.

Footnotes

  • Disclosure. This study was supported by the project of Natural Science Foundation of China (NSFC) (Project Number: 81370855; 81270841). Authors have no conflict of interests, and the work was not supported or funded by any drug company.

  • Received August 28, 2014.
  • Accepted December 1, 2014.
  • Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  1. ↵
    1. Roth JA
    (1980) Reactive pseudosarcomatous response in urinary bladder. Urology 16:635–637.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Alquati S,
    2. Gira FA,
    3. Bartoli V,
    4. Contini S,
    5. Corradi D
    (2013) Low-grade myofibroblastic proliferations of the urinary bladder. Arch Pathol Lab Med 137:1117–1128.
    OpenUrlCrossRefPubMed
    1. Iczkowski KA,
    2. Shanks JH,
    3. Gadaleanu V,
    4. Cheng L,
    5. Jones EC,
    6. Neumann R,
    7. et al.
    (2001) Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol 14:1043–1051.
    OpenUrlCrossRefPubMed
    1. Westfall DE,
    2. Folpe AL,
    3. Paner GP,
    4. Oliva E,
    5. Goldstein L,
    6. Alsabeh R,
    7. et al.
    (2009) Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol 33:99–105.
    OpenUrlPubMed
  3. ↵
    1. Mincik I,
    2. Mytnik M,
    3. Straka L,
    4. Breza JJ,
    5. Vilcha I
    (2013) Inflammatory pseudotumour of urinary bladder. A rare cause of massive macroscopic haematuria. Bratisl Lek Listy 114:495–497.
    OpenUrl
  4. ↵
    1. Rosai J
    (2004) Urinary Bladder. In: Rosai and Ackerman's Surgical Pathology (CV Mosby, St Louis (MO)), 9th ed, 1, pp 1317–1359.
    OpenUrl
  5. ↵
    1. Christopher DM,
    2. Fletcher K,
    3. Unni K,
    4. Mertens F
    (2002) Pathology and genetics of tumors soft tissue and bone (IARC Press, Lyon (FR)), 47–55.
  6. ↵
    1. Harik LR,
    2. Merino C,
    3. Coindre JM,
    4. Amin MB,
    5. Pedeutour F,
    6. Weiss SW
    (2006) Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol 30:787–794.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Kim HW,
    2. Choi YH,
    3. Kang SM,
    4. Ku JY,
    5. Ahn JH,
    6. Kim JM,
    7. et al.
    (2012) Malignant inflammatory myofibroblastic tumor of the bladder with rapid progression. Korean J Urol 53:657–661.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Montgomery EA,
    2. Shuster DD,
    3. Burkart AL,
    4. Esteban JM,
    5. Sgrignoli A,
    6. Elwood L,
    7. et al.
    (2006) Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 30:1502–1512.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Lott S,
    2. Lopez-Beltran A,
    3. Maclennan GT,
    4. Montironi R,
    5. Cheng L
    (2007) Soft tissue tumors of the urinary bladder, Part 1: Myofibroblastic proliferations, benign neo¬plasms, and the tumors of uncertain malignant potential. Hum Pathol 38:807–823.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 36 (3)
Saudi Medical Journal
Vol. 36, Issue 3
1 Mar 2015
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Successful treatment and follow-up of a case of recurrent pseudosarcomatous myofibroblastic proliferation
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Successful treatment and follow-up of a case of recurrent pseudosarcomatous myofibroblastic proliferation
Jun H. Lei, Lu Yang, Liang R. Liu, Qiang Wei
Saudi Medical Journal Mar 2015, 36 (3) 363-365; DOI: 10.15537/smj.2015.3.10149

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Successful treatment and follow-up of a case of recurrent pseudosarcomatous myofibroblastic proliferation
Jun H. Lei, Lu Yang, Liang R. Liu, Qiang Wei
Saudi Medical Journal Mar 2015, 36 (3) 363-365; DOI: 10.15537/smj.2015.3.10149
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Acute myocarditis after COVID-19 vaccination
  • Post COVID-19 pulmonary mass
  • Cardiac myxoma presenting with multisystem involvement
Show more Case Report

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2023 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire